Reducing dopaminergic medication and alternatives for Parkinson's psychosis

Step 1: Document the psychosis symptoms in a daily log. Write down when hallucinations or delusions happen, what the person sees or believes, and whether they are distressed or have insight (know it's not real). This helps the doctor see patterns — for example, if symptoms occur only at night or after a particular medication dose. Bring this log to every appointment.

Step 2: Schedule a medication review with the neurologist or movement disorder specialist. Do not stop or change any Parkinson's medications on your own — sudden withdrawal can cause severe rigidity, fever, and a crisis called neuroleptic malignant syndrome. Ask the doctor: 'Can we try reducing or stopping any of these drugs that might be causing the hallucinations?'

Step 3: Work with the doctor to eliminate anticholinergic drugs first. These include trihexyphenidyl, benztropine, and also medications with anticholinergic effects like some bladder control drugs or older antidepressants (e.g., amitriptyline). The doctor may replace them with safer alternatives. Use the anticholinergic burden scale (available online at acbcalc.com) to check all medications.

Step 4: Ask the doctor to gradually taper amantadine and selegiline, if present. These are often less critical for motor control and are known to cause confusion and psychosis in some people. The doctor will create a slow taper plan over weeks. Stop the taper immediately if the person develops severe rigidity, fever, or confusion, and contact the doctor right away.

Step 5: If psychosis persists, the doctor will then reduce dopamine agonists (like pramipexole, ropinirole, or rotigotine patch). These are more likely to cause psychosis than levodopa. The taper must be very gradual — over weeks to months — to avoid withdrawal symptoms like anxiety, pain, or a severe drop in mobility.

Step 6: If symptoms still continue, the doctor may carefully lower the levodopa dose. This is the most essential drug for movement, so reductions are tiny and slow. The doctor might also switch from controlled-release levodopa (which can cause daytime psychosis) to immediate-release, or adjust the timing of doses to avoid peaks that trigger hallucinations.

Step 7: While reducing medications, implement non-drug strategies to manage the hallucinations. When the person sees something scary, do not argue or tell them it's not real. Instead, say something like: 'I see you're worried about that person over there. Let me check it out — oh, it's just the curtain moving. Let's go have a cup of tea.' Validate their feeling, then gently redirect to a different activity or location.

Step 8: Optimize the environment to reduce triggers. Keep the home well-lit, especially in the evening (twilight hours are common for hallucinations). Reduce clutter, shadows, and confusing patterns on walls or floors. Use nightlights in hallways and bathrooms. Play calming music or nature sounds to reduce auditory hallucinations.

Step 9: Address any underlying medical issues that can worsen psychosis, such as infections (urinary tract infections are common), dehydration, pain, constipation, or sleep deprivation. These can cause delirium, which looks like psychosis but is reversible. Have the doctor check for these before assuming the psychosis is purely from Parkinson's medications.

Step 10: If all else fails and the psychosis is causing severe distress or danger, the doctor may consider a low-dose atypical antipsychotic. The safest options for Parkinson's are pimavanserin (Nuplazid), clozapine, or quetiapine. These require regular blood monitoring (for clozapine) and close follow-up. Always discuss the risks of stroke, falls, and increased mortality with the doctor before starting.